Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL692P is a duplicated pseudogene of the 7SL RNA, located within the human genome. Unlike the canonical 7SL RNA, which serves as an essential component of the signal recognition particle for co-translational targeting of proteins to the endoplasmic reticulum[3][5][7], RN7SL692P does not produce a functional RNA molecule and hence does not participate in any known cellular processes. Pseudogenes like RN7SL692P are generally considered transcriptionally inactive, though some pseudogenes may express non-coding RNA or be implicated as miRNA sponges or small RNA producers, providing regulatory functions; for RN7SL692P specifically, no such function has been identified[1][4][6].
no drug mechanism relevant
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 692, pseudogene (RN7SL692P).